Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,864,322
-
Total 13F shares
-
1,963,743
-
Share change
-
+1,961,100
-
Total reported value
-
$599,087
-
Price per share
-
$0.31
-
Number of holders
-
18
-
Value change
-
+$598,269
-
Number of buys
-
11
-
Number of sells
-
3
Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) as of Q2 2024
As of 30 Jun 2024,
Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,963,743 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, Hudson Bay Capital Management LP, UBS Group AG, HRT FINANCIAL LP, Baader Bank Aktiengesellschaft, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, Tower Research Capital LLC (TRC), and BlackRock Inc..
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.